{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,11,13]],"date-time":"2026-11-13T10:50:07Z","timestamp":1794567007917,"version":"4.9.1"},"reference-count":11,"publisher":"Frontiers Media SA","license":[{"start":{"date-parts":[[2021,2,12]],"date-time":"2021-02-12T00:00:00Z","timestamp":1613088000000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"content-domain":{"domain":["frontiersin.org"],"crossmark-restriction":true},"short-container-title":["Front. Neurol."],"abstract":"<jats:p>Borrelia-specific antibodies in serum did not contribute to the diagnosis of Borrelia arthritis or Borrelia-associated dermatitis in a young woman with ongoing treatment with rituximab due to multiple sclerosis. The diagnosis was confirmed by the detection of Borrelia-DNA in a skin punch biopsy. The patient history did not reveal any tick exposure. She had suffered for several months from fluctuating pain and swelling of the right knee as well as skin involvement with redness and oedema around the ankle of the same leg. Monoarthritis was confirmed by a rheumatologist. Knee puncture was performed but the synovial fluid was only sufficient for microscopic examination of crystals. Neither monosodium urate crystals nor calcium pyrophosphate crystals were found. Borrelia serology in blood revealed borderline levels of immunoglobulin (Ig)M and IgG, respectively. Treatment with doxycycline resulted in resolution of the joint and skin manifestations within a month. This case highlights that Borrelia-specific antibody levels cannot be reliably interpreted in patients who have received B-cell depleting therapy. Under these circumstances, detection of the bacterial genome in different body fluids, such as in the skin, can be a useful complement to the diagnosis of Lyme disease. In this young female, the diagnosis would certainly have been further delayed without the detection of Borrelia-DNA in the skin.<\/jats:p>","DOI":"10.3389\/fneur.2021.645298","type":"journal-article","created":{"date-parts":[[2021,2,13]],"date-time":"2021-02-13T22:31:21Z","timestamp":1613255481000},"update-policy":"https:\/\/doi.org\/10.3389\/crossmark-policy","source":"Crossref","is-referenced-by-count":5,"title":["Case Report: Borrelia-DNA Revealed the Cause of Arthritis and Dermatitis During Treatment With Rituximab"],"prefix":"10.3389","volume":"12","author":[{"given":"Johanna","family":"Sj\u00f6wall","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Georgios","family":"Xirotagaros","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Chris D.","family":"Anderson","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Christopher","family":"Sj\u00f6wall","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Charlotte","family":"Dahle","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"1965","published-online":{"date-parts":[[2021,2,12]]},"reference":[{"key":"B1","doi-asserted-by":"publisher","first-page":"37","DOI":"10.1007\/5584_2020_556","article-title":"Primary immunodeficiencies: diseases of children and adults - a review","volume":"1289","author":"Lewandowicz-Uszynska","year":"2020","journal-title":"Adv Exp Med Biol."},{"key":"B2","doi-asserted-by":"publisher","first-page":"101982","DOI":"10.1016\/j.msard.2020.101982","article-title":"Infections in patients diagnosed with multiple sclerosis: a multi-database study","volume":"41","author":"Persson","year":"2020","journal-title":"Mult Scler Relat Disord."},{"key":"B3","doi-asserted-by":"publisher","first-page":"34","DOI":"10.1111\/ane.12835","article-title":"Infections in patients with multiple sclerosis: Implications for disease-modifying therapy","volume":"136","author":"Celius","year":"2017","journal-title":"Acta Neurol Scand."},{"key":"B4","doi-asserted-by":"publisher","first-page":"364","DOI":"10.1111\/joim.12204","article-title":"A changing treatment landscape for multiple sclerosis: challenges and opportunities","volume":"275","author":"Piehl","year":"2014","journal-title":"J Intern Med."},{"key":"B5","doi-asserted-by":"publisher","first-page":"11","DOI":"10.1111\/ane.12425","article-title":"The Swedish MS registry - clinical support tool and scientific resource","volume":"132","author":"Hillert","year":"2015","journal-title":"Acta Neurol Scand."},{"key":"B6","doi-asserted-by":"publisher","first-page":"316","DOI":"10.3389\/fmed.2020.00316","article-title":"B cell therapy in systemic lupus erythematosus: from rationale to clinical practice","volume":"7","author":"Parodis","year":"2020","journal-title":"Front Med (Lausanne)."},{"key":"B7","doi-asserted-by":"publisher","first-page":"184","DOI":"10.1001\/jamaneurol.2019.3365","article-title":"Infection risks among patients with multiple sclerosis treated with fingolimod, natalizumab, rituximab, and injectable therapies","volume":"77","author":"Luna","year":"2020","journal-title":"JAMA Neurol."},{"key":"B8","doi-asserted-by":"publisher","first-page":"695","DOI":"10.1093\/rheumatology\/ker389","article-title":"Protective effect of A\/H1N1 vaccination inimmune-mediated disease\u2013a prospectively controlled vaccination study","volume":"51","author":"Adler","year":"2012","journal-title":"Rheumatology (Oxford)."},{"key":"B9","doi-asserted-by":"publisher","first-page":"R171","DOI":"10.1186\/ar4358","article-title":"Rituximab and abatacept but not tocilizumab impair antibody response to pneumococcal conjugate vaccine in patients with rheumatoid arthritis","volume":"15","author":"Crnkic Kapetanovic","year":"2013","journal-title":"Arthritis Res Ther."},{"key":"B10","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1007\/BF02112610","article-title":"Polymerase chain reaction for detection of Borrelia burgdorferi DNA in skin lesions of early and late Lyme borreliosis","volume":"14","author":"von Stedingk","year":"1995","journal-title":"Eur J Clin Microbiol Infect Dis."},{"key":"B11","doi-asserted-by":"publisher","first-page":"685","DOI":"10.1016\/j.jaad.2015.10.046","article-title":"Expanding the clinicopathological spectrum of late cutaneous Lyme borreliosis (acrodermatitis chronica atrophicans [ACA]): a prospective study of 20 culture- and\/or polymerase chain reaction (PCR)-documented cases","volume":"74","author":"Lenormand","year":"2016","journal-title":"J Am Acad Dermatol."}],"container-title":["Frontiers in Neurology"],"original-title":[],"link":[{"URL":"https:\/\/www.frontiersin.org\/articles\/10.3389\/fneur.2021.645298\/full","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2021,2,13]],"date-time":"2021-02-13T22:31:23Z","timestamp":1613255483000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.frontiersin.org\/articles\/10.3389\/fneur.2021.645298\/full"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2021,2,12]]},"references-count":11,"alternative-id":["10.3389\/fneur.2021.645298"],"URL":"https:\/\/doi.org\/10.3389\/fneur.2021.645298","relation":{},"ISSN":["1664-2295"],"issn-type":[{"value":"1664-2295","type":"electronic"}],"subject":[],"published":{"date-parts":[[2021,2,12]]},"article-number":"645298"}}